{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:10:08Z","timestamp":1786119008666,"version":"build-2736575974"},"reference-count":30,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2008,10]]},"DOI":"10.1097\/inf.0b013e3181734f8f","type":"journal-article","created":{"date-parts":[[2008,9,26]],"date-time":"2008-09-26T08:37:12Z","timestamp":1222418232000},"page":"886-891","source":"Crossref","is-referenced-by-count":20,"title":["Invasive Pneumococcal Disease Among Human Immunodeficiency Virus-Infected Children, 1989\u20132006"],"prefix":"10.1097","volume":"27","author":[{"given":"Andrew P.","family":"Steenhoff","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah M.","family":"Wood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard M.","family":"Rutstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allison","family":"Wahl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karin L.","family":"McGowan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samir S.","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-6-20210202","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/S0022-3476(05)83170-1","article-title":"Invasive pneumococcal disease among infected and uninfected children of mothers with human immunodeficiency virus infection.","volume":"124","author":"Farley","year":"1994","journal-title":"J Pediatr"},{"key":"R2-6-20210202","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1097\/00006454-200012000-00004","article-title":"Impact of human immunodeficiency virus type 1 on the disease spectrum of Streptococcus pneumoniae in South African children.","volume":"19","author":"Madhi","year":"2000","journal-title":"Pediatr Infect Dis J"},{"key":"R3-6-20210202","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1001\/jama.296.3.292","article-title":"Incidence of opportunistic and other infections in HIV-infected children in the HAART era.","volume":"296","author":"Gona","year":"2006","journal-title":"JAMA"},{"issue":"RR-9","key":"R4-6-20210202","first-page":"1","article-title":"Preventing pneumococcal disease among infants and young children. Recommendations of the Advisory Committee on Immunization Practices (ACIP).","volume":"49","year":"2000","journal-title":"MMWR Recomm Rep"},{"issue":"2","key":"R5-6-20210202","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1542\/peds.106.2.362","article-title":"Policy statement: recommendations for the prevention of pneumococcal infections, including the use of pneumococcal conjugate vaccine (Prevnar), pneumococcal polysaccharide vaccine, and antibiotic prophylaxis.","volume":"106","year":"2000","journal-title":"Pediatrics"},{"key":"R6-6-20210202","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1097\/00006454-200209000-00005","article-title":"Effectiveness of heptavalent pneumococcal conjugate vaccine in children younger than five years of age for prevention of pneumonia.","volume":"21","author":"Black","year":"2002","journal-title":"Pediatr Infect Dis J"},{"key":"R7-6-20210202","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1542\/peds.106.3.505","article-title":"Occult bacteremia from a pediatric emergency department: current prevalence, time to detection, and outcome.","volume":"106","author":"Alpern","year":"2000","journal-title":"Pediatrics"},{"key":"R8-6-20210202","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1097\/01.inf.0000129685.04847.94","article-title":"Postlicensure surveillance for pneumococcal invasive disease after use of heptavalent pneumococcal conjugate vaccine in Northern California Kaiser Permanente.","volume":"23","author":"Black","year":"2004","journal-title":"Pediatr Infect Dis J"},{"key":"R9-6-20210202","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1097\/01.inf.0000157090.40719.9b","article-title":"Comparison of incidence of invasive Streptococcus pneumoniae disease among children before and after introduction of conjugated pneumococcal vaccine.","volume":"24","author":"Haddy","year":"2005","journal-title":"Pediatr Infect Dis J"},{"issue":"3","key":"R10-6-20210202","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1542\/peds.113.3.443","article-title":"Decrease of invasive pneumococcal infections in children among 8 children's hospitals in the United States after the introduction of the 7-valent pneumococcal conjugate vaccine.","volume":"113","author":"Kaplan","year":"2004","journal-title":"Pediatrics"},{"key":"R11-6-20210202","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1097\/01.inf.0000145478.36236.1e","article-title":"Impact of the conjugate pneumococcal vaccine in arkansas.","volume":"23","author":"Schutze","year":"2004","journal-title":"Pediatr Infect Dis J"},{"key":"R12-6-20210202","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1056\/NEJMoa022823","article-title":"Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine.","volume":"348","author":"Whitney","year":"2003","journal-title":"N Engl J Med"},{"key":"R13-6-20210202","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1001\/jama.291.18.2197","article-title":"Impact of childhood vaccination on racial disparities in invasive Streptococcus pneumoniae infections.","volume":"291","author":"Flannery","year":"2004","journal-title":"JAMA"},{"key":"R14-6-20210202","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1001\/jama.295.14.1668","article-title":"Invasive pneumococcal disease among infants before and after introduction of pneumococcal conjugate vaccine.","volume":"295","author":"Poehling","year":"2006","journal-title":"JAMA"},{"key":"R15-6-20210202","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1056\/NEJMoa035060","article-title":"A trial of a 9-valent pneumococcal conjugate vaccine in children with and those without HIV infection.","volume":"349","author":"Klugman","year":"2003","journal-title":"N Engl J Med"},{"key":"R16-6-20210202","article-title":"Performance Standards for Antimicrobial Susceptibility Testing.","year":"2005"},{"key":"R17-6-20210202","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1097\/00006454-198805000-00006","article-title":"Bacterial infections in human immunodeficiency virus-infected children.","volume":"7","author":"Krasinski","year":"1988","journal-title":"Pediatr Infect Dis J"},{"key":"R18-6-20210202","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1097\/00006454-199111000-00004","article-title":"Bacterial infections in human immunodeficiency virus type 1-infected children: the impact of central venous catheters and antiretroviral agents.","volume":"10","author":"Roilides","year":"1991","journal-title":"Pediatr Infect Dis J"},{"key":"R19-6-20210202","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1086\/319750","article-title":"Constancy of distribution of serogroups of invasive pneumococcal isolates among children: experience during 4 decades.","volume":"32","author":"Babl","year":"2001","journal-title":"Clin Infect Dis"},{"key":"R20-6-20210202","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1097\/00006454-199408000-00004","article-title":"Streptococcus pneumoniae in human immunodeficiency virus type 1-infected children.","volume":"13","author":"Gesner","year":"1994","journal-title":"Pediatr Infect Dis J"},{"key":"R21-6-20210202","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1001\/archinte.165.13.1533","article-title":"Epidemiologic changes in bacteremic pneumococcal disease in patients with human immunodeficiency virus in the era of highly active antiretroviral therapy.","volume":"165","author":"Grau","year":"2005","journal-title":"Arch Intern Med"},{"key":"R22-6-20210202","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1086\/500941","article-title":"Emergence of vaccine-related pneumococcal serotypes as a cause of bacteremia.","volume":"42","author":"Steenhoff","year":"2006","journal-title":"Clin Infect Dis"},{"key":"R23-6-20210202","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1086\/429828","article-title":"The impact of a 9-valent pneumococcal conjugate vaccine on the public health burden of pneumonia in HIV-infected and -uninfected children.","volume":"40","author":"Madhi","year":"2005","journal-title":"Clin Infect Dis"},{"key":"R24-6-20210202","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1086\/430604","article-title":"Temporal trends of invasive disease due to Streptococcus pneumoniae among children in the intermountain west: emergence of nonvaccine serogroups.","volume":"41","author":"Byington","year":"2005","journal-title":"Clin Infect Dis"},{"key":"R25-6-20210202","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1097\/INF.0b013e31803df9ca","article-title":"Emergence of 19A as virulent and multidrug resistant Pneumococcus in Massachusetts following universal immunization of infants with pneumococcal conjugate vaccine.","volume":"26","author":"Pelton","year":"2007","journal-title":"Pediatr Infect Dis J"},{"key":"R26-6-20210202","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1086\/516104","article-title":"Streptococcus pneumoniae blood culture isolates from patients with and without human immunodeficiency virus infection: alterations in penicillin susceptibilities and in serogroups or serotypes.","volume":"25","author":"Crewe-Brown","year":"1997","journal-title":"Clin Infect Dis"},{"key":"R27-6-20210202","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1097\/QCO.0b013e328012c5f1","article-title":"HIV and pneumococcal disease.","volume":"20","author":"Klugman","year":"2007","journal-title":"Curr Opin Infect Dis"},{"key":"R28-6-20210202","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1097\/00006454-199907000-00017","article-title":"Nasopharyngeal colonization with Streptococcus pneumoniae in children receiving trimethoprim-sulfamethoxazole prophylaxis.","volume":"18","author":"Abdel-Haq","year":"1999","journal-title":"Pediatr Infect Dis J"},{"key":"R29-6-20210202","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1016\/S0022-3476(05)83169-5","article-title":"Invasive bacterial infections in children born to women infected with human immunodeficiency virus type 1.","volume":"124","author":"Andiman","year":"1994","journal-title":"J Pediatr"},{"key":"R30-6-20210202","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1001\/archpedi.160.8.778","article-title":"Risk factors for opportunistic illnesses in children with human immunodeficiency virus in the era of highly active antiretroviral therapy.","volume":"160","author":"Ylitalo","year":"2006","journal-title":"Arch Pediatr Adolesc Med"}],"container-title":["Pediatric Infectious Disease Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00006454-200810000-00006","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T17:11:49Z","timestamp":1786036309000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00006454-200810000-00006"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,10]]},"references-count":30,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2008]]}},"URL":"https:\/\/doi.org\/10.1097\/inf.0b013e3181734f8f","relation":{},"ISSN":["0891-3668"],"issn-type":[{"value":"0891-3668","type":"print"}],"subject":[],"published":{"date-parts":[[2008,10]]}}}